Skip to main content
. 2024 Sep 14;31(9):5462–5471. doi: 10.3390/curroncol31090404

Figure 2.

Figure 2

Cox-adjusted survival curves from start of last-line chemotherapy until death by baseline performance status (PS) and albumin (alb, ≥35 g/L vs. <35 g/L) among patients with pancreatic cancer (PAN; n = 189) and other gastrointestinal (GI) cancers (n = 289). (A) PAN, PS ≥ 2 vs. 0–1; p < 0.001. (B) GI, PS ≥ 2 vs. 0–1; p < 0.001. (C) PAN, alb ≥ 35 g/L vs. <35 g/L; p = 0.003. (D) GI, alb ≥ 35 g/L vs. <35 g/L; p = 0.003. Model adjusted for age, sex, and hospital catchment area, and additionally for PS at baseline (two categories, (C)), and albumin (two categories, (D)).